Jiuzhou Pharmaceutical (603456.SH) released results for the first three quarters, with net profit of 617 million yuan to mother, a year-on-year decrease of 17.50%

According to the Zhitong Finance App, Jiuzhou Pharmaceutical (603456.SH) disclosed its report for the third quarter of 2026. In the first three quarters, the company achieved operating income of 3,937 billion yuan, a year-on-year decrease of 5.38%; net profit to mother of 617 million yuan, a year-on-year decrease of 17.50%; deducted non-net profit of 615 million yuan, a year-on-year decrease of 17.54%; and basic earnings per share of 0.69 yuan.